Bio-Technology General Overview

  • Year Founded
  • 1980

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 324

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

  • Investments
  • 1

Bio-Technology General General Information

Description

Manufacturer and developer of human health care products based in Kiryat Malachi, Israel. The company's products include large-scale bacterial fermentation, mammalian cell culture, macromolecular separation and purification, aseptic filling of highly viscous liquids in prefilled syringes and recombinant human growth hormone as well as injectable system, thereby lubricating the eye and maintaining low intraocular pressure while facilitating surgery to reduce trauma to the corneal endothelium.

Contact Information

Website
www.btgil.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Beer Tuvia Industrial Zone
  • Post Box 571
  • Kiryat Malakhi 8310402
  • Israel
+972
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • Beer Tuvia Industrial Zone
  • Post Box 571
  • Kiryat Malakhi 8310402
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bio-Technology General Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bio-Technology General‘s full profile, request access.

Request a free trial

Bio-Technology General Patents

Bio-Technology General Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250034206-A1 Method of protein purification Pending 08-Dec-2021
WO-2020016820-A1 Process of, and arrangement for, sterile filtering a non-newtonian liquid and formulation of a liquid obtainable thereby Inactive 18-Jul-2018
WO-2009063307-A2 Inflammatory activity detection method using il-6 Inactive 14-Nov-2007
WO-2009063307-A3 Inflammatory activity detection method using il-6 Inactive 14-Nov-2007
WO-2009063307-A8 Inflammatory activity detection method using il-6 Inactive 14-Nov-2007 G01N33/6869
To view Bio-Technology General’s complete patent history, request access »

Bio-Technology General Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bio-Technology General Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bio-Technology General‘s full profile, request access.

Request a free trial

Bio-Technology General Investments (1)

Bio-Technology General’s most recent deal was a Later Stage VC with Gamida Cell for . The deal was made on 27-Sep-2006.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Gamida Cell 27-Sep-2006 Later Stage VC Biotechnology
To view Bio-Technology General’s complete investments history, request access »

Bio-Technology General Exits (1)

Bio-Technology General’s most recent exit was on 27-Sep-2006 from Gamida Cell. The exit was categorized as with 6 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Gamida Cell 27-Sep-2006 Completed
  • 6 buyers
To view Bio-Technology General’s complete exits history, request access »

Bio-Technology General FAQs

  • When was Bio-Technology General founded?

    Bio-Technology General was founded in 1980.

  • Where is Bio-Technology General headquartered?

    Bio-Technology General is headquartered in Kiryat Malakhi, Israel.

  • What is the size of Bio-Technology General?

    Bio-Technology General has 324 total employees.

  • What industry is Bio-Technology General in?

    Bio-Technology General’s primary industry is Pharmaceuticals.

  • Is Bio-Technology General a private or public company?

    Bio-Technology General is a Private company.

  • What is Bio-Technology General’s current revenue?

    The current revenue for Bio-Technology General is .

  • Who are Bio-Technology General’s investors?

    Savient Pharmaceuticals has invested in Bio-Technology General.

  • When was Bio-Technology General acquired?

    Bio-Technology General was acquired on 01-Jul-2005.

  • Who acquired Bio-Technology General?

    Bio-Technology General was acquired by Ferring.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process